Literature DB >> 6397841

The comparative distribution of monoclonal antibodies to CEA in colorectal xenografts.

J C Lewis, G M Boxer, F Searle, K D Bagshawe.   

Abstract

The in vivo distribution of three different, parenterally administered, monoclonal antibodies to CEA was studied in MAWI human colorectal tumour xenografts. By the use of conventional autoradiography, more antibody was generally detected within necrotic areas, extracellular spaces and stromal connective tissue than within tumour cells. However, some peripheral tumour cell groups markedly accumulated anti-CEA. The number of such groups involved and the degree to which antibody was internalised varied widely with the antibody studied. Immunoperoxidase staining of the same preparations showed that antibody accumulation did not necessarily correspond to CEA-positivity. These findings are compared with results of previous work with polyclonal anti-CEA, and discussed in relation to the use of anti-CEA's as carriers to deliver cytotoxic agents into colorectal tumours.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6397841

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  6 in total

1.  Drug localisation and growth inhibition studies of vindesine-monoclonal anti-CEA conjugates in a human tumour xenograft.

Authors:  G F Rowland; R G Simmonds; V A Gore; C H Marsden; W Smith
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastine.

Authors:  W Smith; V A Gore; D R Brandon; D N Lynch; S A Cranstone; J R Corvalan
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 3.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  The detection of virally induced tumors by 131I- and 125I-labeled syngeneic monoclonal antibodies.

Authors:  D Berends; J L van Gaalen; E H Rhijnsburger; N J de Both; W Breeman; W H Bakker; P Kooy
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.

Authors:  J R Corvalan; W Smith
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

6.  Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry.

Authors:  R B Pedley; G M Boxer; J A Boden; P J Southall; R H Begent; K D Bagshawe; J Humm; F Searle
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.